KUMAMOTO UNIVERSITY

HPH-15, a new compound developed at Kumamoto University, shows promise in diabetes management by lowering blood glucose and combating fat accumulation through AMPK activation. It demonstrates greater efficacy than metformin at lower doses, with reduced risk of lactic acidosis and antifibrotic properties, potentially offering a safer and more versatile treatment option for diabetes and its complications.

Japan's MHLW updated THC limits in CBD products, but experts find the changes insufficient. The guidelines, expected to take effect on December 12, 2024, categorize products like oils and powders, setting THC thresholds. Dr. Yuji Masataka criticizes the definitions, particularly for oils and powders, suggesting they restrict CBD concentrations and raw material imports, calling for additional categories and revised definitions.